Progress and limitations of oral peptide delivery as a potentially transformative therapy-Reference-Cited by-同舟云学术

Progress and limitations of oral peptide delivery as a potentially transformative therapy

Published:2022-02-01 Issue:2 Volume:19 Page:163-178
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Tran Huyen¹,ElSayed Mohamed E.H.²

Affiliation:

1. Senior Advisor, Eli Lilly and Company Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana, USA

2. Senior Research Fellow, Eli Lilly and Company Biotechnology Discovery Research, Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2022.2051476

Reference90 articles.

1. Peptide therapeutics: current status and future directions

2. The Discovery and Development of Liraglutide and Semaglutide

3. Future directions for peptide therapeutics development

4. New perspectives in oral peptide delivery

5. Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain;Molecules;2024-09-05

2. Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates;Nucleic Acids Research;2024-05-14

3. Development and evaluation of C10 and SNAC erodible tablets for gastric delivery of a GIP/GLP1 peptide in monkeys;International Journal of Pharmaceutics;2024-01

4. Materials and structure of polysaccharide-based delivery carriers for oral insulin: A review;Carbohydrate Polymers;2024-01

5. Antimicrobial Peptides and Their Assemblies;Future Pharmacology;2023-10-19